SubsidieMeestersMAGNETIC HYPERTHERMIA FOR METASTASIZED TUMOR TREATMENT AND REMOTE MANIPULATION OF MICRODEVICES
The GIULIa project aims to enhance cancer treatment by using magnetic nanoparticles in natural killer cells for targeted hyperthermia and developing magnetic microdevices for precise drug delivery.
Projectdetails
Introduction
In magnetic hyperthermia (MHT), magnetic nanoparticles (MNPs) convert magneto-energy into heat under a time-varying magnetic field. MHT with MNPs is used in catalysis to promote reactions in solution and in cancer therapy, to ‘burn’ primary tumors in clinic, e.g. Glioblastoma, upon deposition of nanoparticles at the tumor site.
Potential of MHT
The power of MHT, being an externally triggered approach to produce heat, goes beyond these actual uses. In the GIULIa project, I will apply MHT in tasks not yet explored to target the unmet needs of treatment of metastasized tumors and address MHT-mediated locomotion.
Challenges in Current Treatments
MHT treatment of cancer metastases is currently not feasible due to scarce MNP dose accumulation at the spreading tumor sites. In GIULIa, MNPs designed for MHT will be loaded in/on natural killer (NK) immune cells, which, when intravenously injected, will deliver as Trojan horses the right dose of magnetic materials needed for MHT to the metastases.
Enhancing Immune Cell Capabilities
I will aim at raising the capability of NK and CAR-NK immune cells to infiltrate and recognize the tumor. This will merge the synergic toxic effects of NK cells immunotherapy with MHT-heat damage of MNPs.
Innovative Delivery Solutions
Next, magnetic microdevices and their remote locomotion based on MHT-heat gradient represent a new technological solution for delivery purposes with no tissue-depth attenuation for their actuation.
Exploring Heat Localization
Under MHT, I will explore the localization of heat spots on metallic magnetic-based heterostructures as a means to generate bubbles in a liquid and drag an ad hoc designed magnetic microdevice to which the heterostructures are anchored.
Synthesis of Heterostructures
For the scale-up synthesis of metallic-magnetic heterostructures needed for the microdevices, I will merge an in-flow approach with an MHT-route synthesis. The heat at the MNP surface will be used as an in situ energy source to promote the growth of the metallic domain on the MNP.
Impact on Medical Fields
Advanced NK cells and microdevice technology of GIULIa will impact the medical fields of MNP/drug delivery, immunotherapy, and smart robotics.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.993.750 |
| Totale projectbegroting | € 2.993.750 |
Tijdlijn
| Startdatum | 1-2-2023 |
| Einddatum | 31-1-2028 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIApenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Wireless magnetothermal entero-modulationThis project aims to develop a biocompatible magnetic gel for remote activation of intestinal tissue to modulate calcium signaling and neuropeptide release, addressing GI disorders non-invasively. | ERC Starting... | € 1.500.000 | 2024 | Details |
Targeting tertiary lymphoid structures using magneto-marginationThe project aims to develop injectable superparamagnetic particles for non-invasive mapping and thermal destruction of tertiary lymphoid structures to improve diagnosis and treatment of chronic inflammation and cancer. | ERC Consolid... | € 1.970.480 | 2025 | Details |
Mechano-modulation of tumor microenvironment with mechanotherapeutics and sonopermeation to optimize nano-immunotherapyThis project aims to enhance drug delivery and treatment efficacy in desmoplastic tumors by synergistically combining mechanotherapeutics and ultrasound sonopermeation, supported by computational modeling. | ERC Starting... | € 1.500.000 | 2023 | Details |
Tailored Bacterial Magnetic Nanoparticles For Biomedical ImagingThis project aims to revolutionize biomedical applications by developing high-quality, biocompatible magnetic iron oxide nanoparticles using genetically engineered microbes for enhanced functionality and sustainability. | ERC Proof of... | € 150.000 | 2023 | Details |
Hyperpolarized Magnetic Resonance at the point-of-careHYPMET aims to revolutionize personalized cancer treatment by developing a compact NMR technology for real-time monitoring of metabolic pathways and body fluid analyses using enhanced hyperpolarization methods. | ERC Starting... | € 1.499.968 | 2024 | Details |
Wireless magnetothermal entero-modulation
This project aims to develop a biocompatible magnetic gel for remote activation of intestinal tissue to modulate calcium signaling and neuropeptide release, addressing GI disorders non-invasively.
Targeting tertiary lymphoid structures using magneto-margination
The project aims to develop injectable superparamagnetic particles for non-invasive mapping and thermal destruction of tertiary lymphoid structures to improve diagnosis and treatment of chronic inflammation and cancer.
Mechano-modulation of tumor microenvironment with mechanotherapeutics and sonopermeation to optimize nano-immunotherapy
This project aims to enhance drug delivery and treatment efficacy in desmoplastic tumors by synergistically combining mechanotherapeutics and ultrasound sonopermeation, supported by computational modeling.
Tailored Bacterial Magnetic Nanoparticles For Biomedical Imaging
This project aims to revolutionize biomedical applications by developing high-quality, biocompatible magnetic iron oxide nanoparticles using genetically engineered microbes for enhanced functionality and sustainability.
Hyperpolarized Magnetic Resonance at the point-of-care
HYPMET aims to revolutionize personalized cancer treatment by developing a compact NMR technology for real-time monitoring of metabolic pathways and body fluid analyses using enhanced hyperpolarization methods.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulationMETA-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders. | EIC Pathfinder | € 2.987.655 | 2024 | Details |
Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterialsBRAINSTORM aims to develop a scalable wireless neuromodulation technology using smart magnetic nanomaterials to selectively control deep brain neurons for therapeutic applications in Fragile X syndrome. | EIC Pathfinder | € 3.083.850 | 2023 | Details |
Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.NuCapCure aims to develop novel cancer treatments for glioblastoma by utilizing custom-made drugs through biosynthesis to enhance proton and neutron therapies for better targeting and efficacy. | EIC Pathfinder | € 5.972.875 | 2024 | Details |
A synaptic mechanogenetic technology to repair brain connectivityDeveloping a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy. | EIC Pathfinder | € 3.543.967 | 2023 | Details |
RESTORING IMMUNITY CONTROL OF GI CANCERSTIMNano aims to develop a novel cancer immunotherapy platform using targeted biodegradable nanoparticles to enhance immune responses against gastrointestinal cancers, progressing through clinical trials and commercialization. | EIC Transition | € 2.007.750 | 2025 | Details |
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation
META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.
Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterials
BRAINSTORM aims to develop a scalable wireless neuromodulation technology using smart magnetic nanomaterials to selectively control deep brain neurons for therapeutic applications in Fragile X syndrome.
Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.
NuCapCure aims to develop novel cancer treatments for glioblastoma by utilizing custom-made drugs through biosynthesis to enhance proton and neutron therapies for better targeting and efficacy.
A synaptic mechanogenetic technology to repair brain connectivity
Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.
RESTORING IMMUNITY CONTROL OF GI CANCERS
TIMNano aims to develop a novel cancer immunotherapy platform using targeted biodegradable nanoparticles to enhance immune responses against gastrointestinal cancers, progressing through clinical trials and commercialization.